Investigating glatiramer acetate for relapsing–remitting multiple sclerosis at the double dose—is more better?

被引：0
|
作者：
Peter A Calabresi
机构：
[1] PA Calabresi is Associate Professor of Neurology and Director of the Johns Hopkins Multiple Sclerosis Center,
[2] Baltimore,undefined
[3] MD,undefined
[4] USA.,undefined
来源：
Nature Clinical Practice Neurology | 2007年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：540 / 541
页数：1
相关论文
共 50 条
  • [21] In vivo monitoring of neuroprotection by glatiramer acetate in patients with relapsing-remitting multiple sclerosis
    Ehling, R.
    Di Pauli, F.
    Kuenz, B.
    Millonig, A.
    Lutterotti, A.
    Gneiss, C.
    Santner, W.
    Schocke, M.
    Loescher, W.
    Deisenhammer, F.
    Reindl, M.
    Berger, T.
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S243 - S243
  • [22] Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis
    Waschbisch, Anne
    Atiya, Monika
    Linker, Ralf A.
    Potapov, Sergej
    Schwab, Stefan
    Derfuss, Tobias
    [J]. PLOS ONE, 2011, 6 (09):
  • [23] Randomised, double-blind, parallel-group, dose-comparison study of glatiramer acetate in relapsing-remitting multiple sclerosis
    Cohen, J.
    Rovaris, M.
    Goodman, A.
    Wynn, D. R.
    Ladkani, D.
    Filippi, M.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S99 - S100
  • [24] Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance
    Harrison, Daniel M.
    Gladstone, Douglas E.
    Hammond, Edward
    Cheng, Jeffrey
    Jones, Richard J.
    Brodsky, Robert A.
    Kerr, Douglas
    McArthur, Justin C.
    Kaplin, Adam
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (02) : 202 - 209
  • [25] Is Severity of Adverse Events Affected by the Dose and Frequency of Glatiramer Acetate Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)?
    Wu, Y.
    Gandhi, S.
    Grinspan, A.
    Kolodny, S.
    Zagmutt, F. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 333 - 333
  • [26] Localized lipoatrophy after glatiramer acetate injection in patients with remitting-relapsing multiple sclerosis
    Drago, F
    Brusati, C
    Mancardi, G
    Murialdo, A
    Rebora, A
    [J]. ARCHIVES OF DERMATOLOGY, 1999, 135 (10) : 1277 - 1278
  • [27] Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis
    Boster, Aaron L.
    Ford, Corey C.
    Neudorfer, Orit
    Gilgun-Sherki, Yossi
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (06) : 575 - 586
  • [28] Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis
    Kalincik, Tomas
    Jokubaitis, Vilija
    Izquierdo, Guillermo
    Duquette, Pierre
    Girard, Marc
    Grammond, Pierre
    Lugaresi, Alessandra
    Oreja-Guevara, Celia
    Bergamaschi, Roberto
    Hupperts, Raymond
    Grand'Maison, Francois
    Pucci, Eugenio
    Van Pesch, Vincent
    Boz, Cavit
    Iuliano, Gerardo
    Fernandez-Bolanos, Ricardo
    Flechter, Shlomo
    Spitaleri, Daniele
    Cristiano, Edgardo
    Verheul, Freek
    Lechner-Scott, Jeannette
    Amato, Maria Pia
    Antonio Cabrera-Gomez, Jose
    Saladino, Maria Laura
    Slee, Mark
    Moore, Fraser
    Gray, Orla
    Paine, Mark
    Barnett, Michael
    Havrdova, Eva
    Horakova, Dana
    Spelman, Timothy
    Trojano, Maria
    Butzkueven, Helmut
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (09) : 1159 - 1171
  • [29] Glatiramer acetate following mitoxantrone induction in relapsing-remitting multiple sclerosis: extended experience
    Ramtahal, Jason
    Boggild, Mike
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S175 - S175
  • [30] Glatiramer acetate (Copaxone) treatment in relapsing-remitting multiple sclerosis: Quantitative MR assessment
    Ge, Y
    Grossman, RI
    Udupa, JK
    Fulton, JC
    Babb, JS
    Constantinescu, CS
    [J]. RADIOLOGY, 1999, 213P : 441 - 441
12345